<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
RVPH
Reviva Pharmaceuticals
$
()


  • Reviva Pharmaceuticals announces vocal biomarker data from RECOVER trial

    9/9/2024 - 08:18am
  • Reviva Pharmaceuticals to hold a virtual key opinon leader event

    9/4/2024 - 13:50pm
  • Reviva Pharmaceuticals to hold a virtual key opinon leader event

    9/4/2024 - 10:09am
  • Reviva to host KOL event on vocal biomarker data from RECOVER trial

    8/27/2024 - 08:07am
  • Reviva Pharmaceuticals 4.76M share Secondary priced at $1.05

    8/21/2024 - 06:31am
  • Maxim gets more bearish on Reviva Pharmaceuticals, downgrades shares

    8/16/2024 - 07:21am
  • Reviva Pharmaceuticals announces anticipated milestones

    8/14/2024 - 08:03am
  • Reviva Pharmaceuticals reports Q2 EPS (26c), consensus (29c)

    8/14/2024 - 08:02am
  • Reviva announces grant of U.S. patent covering use of brilaroxazine

    8/6/2024 - 08:23am
  • Reviva Pharmaceuticals announces grant of European patent on brilaroxazine

    7/9/2024 - 08:09am
  • Reviva Pharmaceuticals price target lowered by $6 at H.C. Wainwright, here's why

    6/11/2024 - 06:06am
  • Reviva announces enrollment update for OLE study on brilaroxazine

    5/15/2024 - 08:14am
  • Reviva Pharmaceuticals reports Q1 EPS (25c), consensus (38c)

    5/14/2024 - 08:07am
  • Reviva Pharmaceuticals announces FDA alignment on brilaroxazine trial

    4/15/2024 - 08:35am
  • Reviva Pharmaceuticals announces anticipated milestones, events

    4/15/2024 - 08:09am
dynamic_feed Breaking News